Share on StockTwits

Discovery Laboratories (NASDAQ:DSCO) announced its earnings results on Thursday. The company reported ($0.14) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.13) by $0.01, AmericanBankingNews.com reports.

On a related note, analysts at Roth Capital cut their price target on shares of Discovery Laboratories from $6.00 to $5.50 in a research note on Wednesday, March 19th.

Discovery Laboratories (NASDAQ:DSCO) traded down 1.83% on Thursday, hitting $1.61. The stock had a trading volume of 140,484 shares. Discovery Laboratories has a 1-year low of $1.50 and a 1-year high of $3.05. The stock’s 50-day moving average is $2.05 and its 200-day moving average is $2.24. The company’s market cap is $136.4 million.

Discovery Laboratories, Inc is a biotechnology company focused on creating life-saving products for critical care patients with respiratory disease.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.